NKTR - Nektar Therapeutics' (NKTR) CEO Howard Robin on Q4 2021 Results - Earnings Call Transcript

Nektar Therapeutics (NKTR) Q4 2021 Earnings Conference Call February 28, 2022 5:00 PM ET Company Participants Jennifer Ruddock – Head-Corporate Affairs Howard Robin – President and Chief Executive Officer Dimitry Nuyten – Chief Medical Officer Jonathan Zalevsky – Chief-Research and Development Gil Labrucherie – Chief Operating Officer and Chief Financial Officer Conference Call Participants Peter Lawson – Barclays CJ Zopf – Goldman Sachs Jessica Fye – JPMorgan Greg Harrison – Bank of America Bert Hazlett – BTIG Mara Goldstein – Mizuho Andy Hsieh – William Blair Presentation Operator Good day. And thank you for standing by. Welcome to the Nektar Therapeutics Fourth Quarter 2021 Financial Results Conference Call. [Operator Instructions] Please be advised that today's conference may be recorded. If you require any further assistance, I would now like to hand the conference over to your speaker today, Jennifer Ruddock, Head of Corporate Affairs. Please go ahead. Jennifer Ruddock Thank

For further details see:

Nektar Therapeutics' (NKTR) CEO Howard Robin on Q4 2021 Results - Earnings Call Transcript